U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07174609) titled 'Scrambler Therapy in Chronic Pancreatitis' on Sept. 11.
Brief Summary: The investigators will enroll adults with chronic pancreatitis who have persistent abdominal pain not relieved by standard treatments. This study will test the feasibility and effectiveness of Scrambler Therapy, a non-invasive FDA-cleared device that delivers "non-pain" electrical signals through the skin to retrain the brain's pain perception. Participants will undergo 5-10 treatment sessions and be followed for 3 months with standardized pain scores and quality-of-life assessments. The goal is to generate pilot data to support larger studies of Scrambler Thera...